Conference abstractPublished 2 Nov 2015
New human malaria parasite Plasmodium falciparum dihydroorotate dehydrogenase inhibitors by pharmacophore and structure-based virtual screening
1University of Cape Town, South Africa 2University of Texas Southwestern Medical Center, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Malaria continues to cause a severe global health problem as many approved drugs face widespread drug-resistance and no effective vaccines are available for this disease. Plasmodium falciparum dihydroorotate dehydrogenase (PfDHODH) is an attractive drug target as it plays a key role in the de novo pyrimidine biosynthetic pathway, which Plasmodium falciparum depends exclusively on for survival. In this study, several 3D-QSAR pharmacophore models were developed based on the known PfDHODH inhibitors. The reliability of the models was validated using the external test set, cost analysis, FischerâÂ?Â?s randomization method and virtual screening experiment. The result indicated that the Hypo 1 model is capable of discriminating between the active and inactive PfDHODH inhibitors and was accordingly employed as a 3D search query for virtual screening of the National Cancer Institute database. Subsequently, the hit compounds were refined in the PfDHODH binding site using molecular docking and Molecular Mechanics/Generalized Born Surface Area. The combination of the pharmacophore and structure-based virtual screening resulted in the identification of three PfDHODH inhibitors that showed IC50 values against the enzyme in the range of 0.38âÂ?Â?20 Ã?¼M. The most active compound also showed an IC50 value of 26 Ã?¼M against the parasite as well as the species-selectivity over human DHODH. In addition to this, sixteen compounds inhibited parasite growth with IC50 âÂ?¤ 50 Ã?¼M, four of which showed IC50 values in the range of 5âÂ?Â?12 Ã?¼M. The compounds may be further explored in the identification and development of more potent PfDHODH and parasite growth inhibitors.
Subjects
ChemistryPharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalMedicinal Chemistry
- SubjectChemistry
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Elumalai Pavadai”
- BylineArticles whose byline prints “Farah El Mazouni”
- BylineArticles whose byline prints “Margaret A Phillips”
- BylineArticles whose byline prints “Kelly Chibale”
